Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irbesartan, Doxycycline and a Combination on Markers of Vascular Dysfunction in the Marfan Syndrome
NCT01949233Phase 2Unknown
- Sponsor
- University of Oxford
- Start
- Oct 2013
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irbesartan, doxycycline in Marfan syndrome (MFS), sponsored by University of Oxford. Status: unknown.
02
Drugs
irbesartandoxycycline
03
Conditions
Marfan syndrome (MFS)
Beyond the preview
Go deeper on NCT01949233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01949233.